推进中风诊断:对人工智能在非对比CT (NCCT) 上检测早期缺血变化的全面审查
Ines Ben Alaya1, Fethi Felhi2, Mariem Messelmani2
1Laboratory of Biophysics and Medical Technology, Higher Institute of Medical Technology of Tunis, University of Tunis El Manar, Tunisia (I.B.A, S.L.).
Academic radiology
|November 25, 2025
概括
人工智能 (AI) 有助于检测急性缺血性中风的非对比计算机断层扫描中的早期缺血性变化. 像深度学习这样的AI工具可以客观地量化大脑损伤,改善诊断和患者选择治疗.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 人工智能的人工智能
背景情况:
- 在非对比计算断层扫描 (NCCT) 上检测早期缺血性变化 (EIC) 对急性缺血性中风 (AIS) 反疗法至关重要.
- 鉴定微妙的EIC是具有挑战性的,因为变化,读者专业知识的依赖,和观察者之间的分歧.
- 需要对早期缺血性脑损伤进行客观量化,特别是在资源有限的环境中.
研究的目的:
- 审查当前的人工智能 (AI) 应用程序,用于在AIS中检测NCCT图像上的EIC.
- 突出AI在自动化缺血损伤客观评估和改善诊断一致性的潜力.
- 探索人工智能在提高AIS管理和患者治疗结果方面的作用.
主要方法:
- 审查当前的AI应用程序,重点是用于EIC检测的机器学习 (ML) 和深度学习 (DL).
- 讨论使用人工智能计算阿尔伯塔中风计划早期计算机断层扫描得分 (ASPECTS) 的自动化计算,以客观地量化低衰减.
- 检查基于深度学习 (DL) 的EIC检测方法,利用大规模数据集.
主要成果:
- 人工智能能够快速,一致和准确地分析NCCT图像以进行EIC检测.
- 自动化ASPECTS计算和基于DL的检测显示出对客观性缺血损伤评估的希望.
- 人工智能工具可以补充临床专业知识并简化诊断工作流程.
结论:
- 人工智能,特别是ML和DL,为改善AIS中EIC的检测和量化提供了巨大的潜力.
- 这些人工智能创新可以提高诊断客观性,效率和潜在的患者结果.
- 进一步的研究和开发对于实现AI在AIS管理中的全面转型作用至关重要.
相关概念视频
Imaging Studies for Cardiovascular System V: CT
264
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
264
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
374
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
374


